Results
Of 40 patients, 21 started on isocarboxazid and 19 on nortriptyline.
Of the 19 who completed isocarboxazid therapy, 12 were considered well after th.ree~eeks. Of the~7 completing nortriptyline therapy, mne improved correspondingly.
Statistical examination of the detailed results confirmed that the two groups did not differ significantly.
Of fiv: who failed to respond to isocarboxazid and subsequently received placebo, one responded; none of the remaini?g~our responded to subsequent nortriptyline. Of five who failed to respond to nortriptyline and subsequently received placebo, one responded; of the four going on to isocarboxazid, two responded.
After six months eight of the 12 who had responded to isocarboxazid were known to be well and three of thesẽ ere sti.ll receiving medication. Of the rune patIents who had responded to nortriptyline seven were known to be well, of .whom six were still receiving medication,
Cliuical Factors aud Outcome
The ways in which the patients' illnesses had supervened were assessed at he outset~nd classified where possible I!~to neurotIC-?nset and depressive-onset. FIfteen neurotic-onset and 16 depressiveonset illnesses were identified; 6 and 11 resp:cti~ely responded to antidepressive medication, a result not significant in itself but tending to confirm the previous-London, ly noted, statistically significant, tendency. for neurotic-onset psychotic de-preSSIOns to respond less well. Here also, 307 In a blind comparative trial Richmond and Roberts (5) treated psychotically depressed outpatients with imipramine, amitriptyline, tranylcypromine or isocarboxazid,t and determined that the best response was made to isocarboxazid. A prediction of differential response to antidepressive medication, on the basis of the mode of onset of the depressive illness, was blindly made on Richmond's and Roberts' patients (3) and it was found that those whose illnesses started with neurotic symptoms fared significantly less well than those whose illnesses were recognizably depressive from the start, even though the final syndrome in both groups was one of psychotic depression.
In this trial, nortriptylinett was assessed in the same manner, comparing it with isocarboxazid, and the modes of onset of the depressive illnesses, together with apparent :etiological factors, were noted before therapy was started. As in previous trials at this clinic, all patients were diagnosed (psychotic depression) by other consultants and all were assessed blindly by one investigator on Hamilton's (2) Depression Rating Scale at each visit. They were also seen separately by one of the authors (P.H.) who controlled treatment.
Patients were randomly allocated to an active agent, and if they failed to respond after three weeks they received placebo medication (because an interval is necessary between the administration of these drugs) and then the alternative active agent. The full dose used for nortriptyline was 100 mg. daily and that for°M anuscript Received April, 1968. 'Associate Professor, University of Alberta, Edmonton.
'Senior Registrar, St. George's Hospital, Ens-land. tMarplan. ttAventyl. Canad. Psychiat, Ass. J. Vol. 14 (1969) there was no evidence of differential drug action. Likewise, the finding in Hays' survey of psychotic depression, that where anxiety symptoms heralding a psychotic depression cannot be dynamically explained, they may often be traced to an influenza-like illness, was corroborated, since of six of these psychotic depressions which were so precipitated, five demonstrated a neurotic form of onset; only one of the six responded to antidepressive drugs.
Discussion
Nortriptyline and isocarboxazid seem equally effective in psychotically depressed outpatients, and the equivalence of this trial to that of Richmond and Roberts probably means that nortriptyline, like the isocarboxazid they assessed, is better than tranylcypromine, amitriptyline or imipramine.
Few studies compare nortriptyline and isocarboxazid, but Ravn's (4) results correspond to ours. Others have noted the tendency for patients who did not respond to one type of antidepressive (M.A.O.!. or tricyclic) to fail subsequently to respond to the other (1).
Summary
Nortriptyline and isocarboxazid were blindly compared in a trial on psychotically depressed outpatients. Response was roughly equal in each group; some clinical prognostic guides, noted in a previous trial, were confirmed.
